JMS Co.,Ltd.

7702.T
Medical Instruments & Supplies
2026/11/06 19:48 Updated
Market Cap: $65.9M (¥10.4B)
Stock Price: $2.69 (¥426)
Exchange Rate: 1 USD = ¥158.48

JMS Co.,Ltd. PRESS RELEASE – Notice Regarding Differences Between Forecasts and Actual Results for the Interim Consolidated Fiscal Period for the Fiscal Year Ending March 2027 and Revision of Full-Year Consolidated Earnings Forecast

Net sales for the interim period exceeded the previous forecast, but operating income, ordinary income, and net income attributable to owners of parent for the interim period fell short. The full-year forecast is expected to be revised upward for net sales but downward for profits compared with the previous forecast. The main causes are higher raw material costs and low production utilization.

Importance:
Page Updated: November 7, 2026
IR Disclosure Date: November 6, 2026

Key Figures

  • Net Sales 32,391 million yen (Previous forecast 31,600 million yen)
  • Operating Income 9 million yen (Previous forecast 350 million yen)
  • Ordinary Income -145 million yen (Previous forecast 300 million yen)
  • Net Income Attributable to Owners of Parent (Interim) -262 million yen (Previous forecast 200 million yen)
  • Net Income Per Share (Interim) -10.69 yen (Previous 8.16 yen)

AI要約

Performance Trends and Full-Year Outlook

Analysis of differences for the interim consolidated fiscal period of the fiscal year ending March 2027 shows that net sales exceeded expectations due to recovery in orders for major overseas products and expanded sales of domestic focus products. However, operating income, ordinary income and net income fell short of forecasts due to sustained high raw material costs and the impact of low utilization in the first quarter. For the full year, net sales are expected to exceed the previous forecast, but profits are likely to fall short of the previous forecast as the effects of low utilization through the first half and higher costs are expected to persist.

Outlook and Points to Note

Exchange rate effects and persistently high raw material prices may affect profitability. We plan to implement measures to improve earnings such as price revisions, cost reductions, and expense curtailment. Improving operations at overseas sites and continued expansion of domestic product sales are expected to remain key to performance.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

JMS Co.,Ltd.

Company overview · Stock price · Financial data · All IR

View company page →